Aacp Core List of Journals for Pharmacy Education
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Future Role of Molecular and Cell Biology in Medical Practice in the Tropical Countries
The future role of molecular and cell biology in medical practice in the tropical countries David Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK Downloaded from https://academic.oup.com/bmb/article/54/2/489/285007 by guest on 27 September 2021 Molecular and cell biology have a great deal to offer tropical medicine in the future. As well as helping to understand the population genetics and dynamics of both infectious and non-infectious diseases, they promise to provide a new generation of diagnostic and therapeutic agents, and to play a major role in the development of new vaccines and other approaches to the control of disease in tropical communities. Over the last 20 years there has been a gradual shift in the emphasis of basic biomedical research from the study of disease in patients and their organs to its definition at the level of molecules and cells. This new trend has been underpinned by a remarkable new technology which has made it possible to isolate and sequence genes, study their function and transfer them across the species barrier. In the short time during which this field has evolved, a great deal has been discovered about human pathology at the molecular level. Many monogenic diseases have been characterised, much has been learnt about the molecular and cell biology of cancer, and a start has been made in defining the different genes that comprise the complex interactions between nature and nurture that underlie many of the major killers of Western society. Enough is known already to suggest that this knowledge will have major implications for the development of more precise diagnostic and therapeutic agents in the future. -
Molecular Medicine Degree: Doctor of Philosophy (Phd)
In the Name of God Islamic Republic of Iran Ministry of Health and Medical Education Deputy for Education Molecular Medicine Degree: Doctor of Philosophy (PhD) Total Course Credits Core: 24 Non-core (Electives): 6 Dissertation: 20 Program Description Although the concept of molecular medicine was introduced in 1949, a great deal of developments in this filed, especially in European and American countries, has taken place during recent years. Bearing in the mind the strategic significance of this area of knowledge, a considerable number of universities worldwide grant scholarships annually to students of this field of study. Iranian universities inaugurated Molecular Medicine in 2007 and due to the urgent escalating need for graduates of molecular medicine each year, an increasing number of universities receive students in this major. Molecular medicine, as an interdisciplinary field of study, contributes to understanding the molecular basis of the etiology and mechanisms of diseases and various disorders along with fundamental and heuristic research on different areas of diseases including prevention, diagnosis, and treatment. Dissemination of the science of molecular medicine through a blend of education and clinical research emphasizing active learning and up-to-date research will significantly contribute to the expansion of the borders of medicine and eventually improvement of health in society. Among the values of the field are practicing creativity and innovation to analyze lessons learned and research to utilize molecular medicine findings to solve problems related to public health. In this regard, graduates focus on social justice and human equality, the rights of patients, regardless of age, sex, color, race, culture and religion and any activity would be with regard to the protection of human dignity. -
A Time of Two Pandemics
Issue 42 Summer 2020 ISSN 2045-1563 (print) ESEThe newsletter of the EuropeanNews Society of Endocrinology ISSN 2045-1571 (online) A time of two pandemics In this issue Endocrinology responds to COVID-19 Understanding obesity: metabolism and more Don’t miss e-ECE 2020 www.ece2020.org 5−9 September CONTENTS & EDITORIAL In this issue Editorial Society News The world has seen much change since the last issue of 03 Introducing e-ECE 2020 ESE News. It has affected all 04 The making of a virtual Congress, our lives, but it is heartening plus Metformin for steroid side effects to find that, around the globe, communities have 05 Andrea Giustina: your President’s united and become stronger. perspective, plus From the ESE Office In just such a way, we – the members of the endocrine ESE Committees community – have worked together unstintingly, 06 A time of twin challenges, and to meet unprecedented An early career in obesity research challenges in our professional Features and personal lives. 07 Endocrinology in the time of COVID-19 Our Society, ESE, has stood alongside us to provide support, while COVID-19 has disrupted the way we care for patients and the way 08 Obesity – the link with reproduction we perform research. The huge range of ESE initiatives (see page 5) 10 Obesity, cancer and a role for epigenetics has included the Society’s widely downloaded statement on patient 12 The Endo Explorer: Gilles Mithieux on management, and European Journal of Endocrinology’s series of essential articles on ‘Endocrinology in the time of COVID-19’ (page 7). -
Journal Title Records % of 292 JOURNAL of PEDIATRIC ENDOCRINOLOGY METABOLISM 11 3.767 HORMONE RESEARCH in PAEDIATRICS 7 2.397 PL
Journal title Records % of 292 JOURNAL OF PEDIATRIC ENDOCRINOLOGY METABOLISM 11 3.767 HORMONE RESEARCH IN PAEDIATRICS 7 2.397 PLOS ONE 6 2.055 JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY 6 2.055 JOURNAL OF KOREAN MEDICAL SCIENCE 5 1.712 EUROPEAN JOURNAL OF ENDOCRINOLOGY 5 1.712 SCIENTIFIC REPORTS 4 1.37 REPRODUCTIVE TOXICOLOGY 3 1.027 JOURNAL OF CLINICAL ENDOCRINOLOGY METABOLISM 3 1.027 BONE 3 1.027 TOXICOLOGY IN VITRO 2 0.685 TOXICOLOGY AND APPLIED PHARMACOLOGY 2 0.685 SEXUAL DEVELOPMENT 2 0.685 PAEDIATRICS AND INTERNATIONAL CHILD HEALTH 2 0.685 MOLECULAR AND CELLULAR ENDOCRINOLOGY 2 0.685 MEDICINE 2 0.685 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 2 0.685 JOURNAL OF PEDIATRICS 2 0.685 JOURNAL OF PEDIATRIC SURGERY 2 0.685 JOURNAL OF DIABETES INVESTIGATION 2 0.685 JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE 2 0.685 IRANIAN JOURNAL OF MEDICAL SCIENCES 2 0.685 INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY 2 0.685 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2 0.685 INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC H2EALTH0.685 INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH 2 0.685 INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2 0.685 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 2 0.685 INDIAN JOURNAL OF PEDIATRICS 2 0.685 HORMONE AND METABOLIC RESEARCH 2 0.685 FRONTIERS IN ENDOCRINOLOGY 2 0.685 EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY DIABETES 2 0.685 ENVIRONMENTAL RESEARCH 2 0.685 ENDOCRINE 2 0.685 DIABETES 2 0.685 CLINICAL GENETICS 2 0.685 CLINICA CHIMICA ACTA 2 0.685 CHINESE -
Fall-2020-Print-Axia
INSIDE THIS SPECIAL FALL 2020 Contents EDITION OF ACS AXIAL axial.acs.org deeper ACS PUBLICATIONS SHANGHAITECH UNIVERSITY NEW ENVIRONMENTAL SCIENCE & WHAT CHEMISTS NEED LAUNCHESdive NEW JOURNALS PARTNERS WITH ACS PUBLICATIONS TO TECHNOLOGY JOURNALS TO KNOW ABOUT Explore the ResearchFOCUSED behind ON theFOOD 2020 AND Journal Citation Reports® LAUNCH ACCOUNTS OF MATERIALS NAME EDITORS AND MACHINE LEARNING AGRICULTURAL CHEMISTRY RESEARCH OPEN FOR SUBMISSIONS The 2020 Journal Citation Reports® (JCR) show the vital role ACS Publications journals play in publishing important, highly cited research. Thanks to the dedication and brilliance of our authors and reviewers, 89% of ACS journals have an Impact Factor greater than 3 this year. Browse this year’s JCR figures, which are based on citations from 2018 to 2019: EXPLORE THE RESEARCH HOW ACS IS SUPPORTING THE LEARN HOW ACS SUPPORTS SCIMEETINGS: PRESENT YOUR RESEARCH BEHIND THE 2020 JOURNAL CHEMISTRY COMMUNITY DURING THE OPEN SCIENCE BEYOND THE ACS FALL 2020 VIRTUAL CITATION REPORTS® COVID-19 PANDEMIC MEETING & EXPO Impact Factor 20.832 Impact Factor 4.473 Impact Factor Impact Factor 4.152 8.758 Impact Factor Impact Factor 4.486 Impact Factor 12.685 12.350 Impact Factor 4.434 Impact Factor Impact Factor 3.381 19.003 Impact Factor 3.418 Impact Factor Impact Factor 3.975 Impact Factor 4.614 6.042 Impact Factor Impact Factor Impact Factor 7.333 14.588 6.864 Impact Factor 2.870 Impact Factor Impact Factor 6.785 4.411 Impact Factor 7.632 Impact Factor 6.092 Impact Factor 2.865 Impact Factor 4.031 pubs.acs.org/acsagscitech ACS PUBLICATIONS LAUNCHES NEW JOURNALS FOCUSED ON FOOD AND AGRICULTURAL CHEMISTRY ournal of Agricultural and Food Chemistry Technical University of Munich and the chair of is growing into a family of journals with the Food Chemistry and Molecular Sensors. -
Marnix Medema Curriculum Vitae
Page 1 of 10 Curriculum vitae Personal Information FIRST NAME / SURNAME Marnix Medema ADDRESS (PRIVATE) Soetendaalseweg 16A, 6721XB Bennekom, NL ADDRESS (WORK) Droevendaalsesteeg 1, 6708PB Wageningen, NL TEL +31317484706 / +31654758321 (cell) EMAIL [email protected] WEB http://www.marnixmedema.nl NATIONALITY Dutch DATE OF BIRTH 24.01.1986 GENDER Male Work Experience & Education DATES March 2015 - present EMPLOYER Wageningen University, Wageningen, The Netherlands POSITION Assistant Professor DATES August 2013 - February 2015 EMPLOYER MPI for Marine Microbiology, Bremen, Germany POSITION Postdoctoral Researcher DATES September 2010 - March 2011 EMPLOYER University of California, San Francisco, USA POSITION Visiting Research Scholar DATES September 2009 - August 2013 EMPLOYER University of Groningen, The Netherlands POSITION PhD Student DATE / DISTINCTION 27.09.2013, cum laude ** DATES September 2006 - August 2008 QUALIFICATION AWARDED Master of Science Biomolecular Science, cum laude ** INSTITUTION University of Groningen, The Netherlands DATES September 2003 - August 2006 QUALIFICATION AWARDED Bachelor of Science Biology, cum laude ** INSTITUTION Radboud University Nijmegen, The Netherlands ** In the Netherlands, only two classes of honors are used: eervolle vermelding ("honorable mention") and cum laude, typically only to mark exceptional achievement. [...] Generally, less than 20% receive the "honorable mention" distinction, and "cum laude" is even harder to attain (less than 1%-5% depending on the university and study program). -
Support for Authors Apcs
PUBLICATION SUPPORT FOR AUTHOR ARTICLE PROCESSING CHARGES (APCs) Selected UT Southwestern Library journal subscriptions provide discounted Article Processing Charges (APCs) for authors. Publishers use discounted APCs to encourage open access (OA) publishing. Publishers do not apply discounts automatically. The corresponding UT Southwestern author should inform the publisher of the Library benefit when submitting articles. This list is as comprehensive as possible. As we learn about additional APC discounts, we will continue to update this list. ACS Publications (American Chemical Society) The Library’s All Publications ACS subscription guarantees an APC discount for UTSW authors in various ACS publications. Additionally, individual ACS members may also be eligible for discounts. More information: https://pubs.acs.org/page/4authors/authorchoice/index.html Biochemical Society (Portland Press) All articles accepted for publication from corresponding UTSW authors will be automatically published in the following journals as open access with no separate article processing charges: • Biochemical Journal • Emerging Topics in Life Sciences • Biochemical Society Transactions • Essays in Biochemistry • Bioscience Reports • Neuronal Signaling • Clinical Science Cost avoidance of APC charges results from Library funding of the publisher's transformative “read and publish” combined subscription model. More information: https://portlandpress.com/pages/open_access_policy BMJ Case Reports Note: This is not an open access program. A benefit of the Library’s subscription to this journal is cost avoidance for author submission of case reports. Because of the Library's Institutional Fellowship, corresponding UTSW authors do not need to pay the Individual Fellowship Fee to publish in this journal. You must include the Institutional Fellowship code when submitting case studies for publication. -
The Journal of Clinical Pharmacology
The Journal of Clinical Pharmacology Activity Report Issues 47: 1 – 3 January – March 2007 Contents Circulation...................................................................................................................................................................3 Commercial Sales .......................................................................................................................................................5 Summary .................................................................................................................................................................................... 5 Commercial Reprints ................................................................................................................................................................ 6 Supplements .............................................................................................................................................................................. 7 Journal Activity Summary ........................................................................................................................................7 Production.................................................................................................................................................................................. 7 Abstracting & Indexing ............................................................................................................................................................ 8 Thomson Scientific -
Syllabus-Bio 656: Molecular Medicine and Mechanisms of Disease Fall 2016
SYLLABUS-BIO 656: MOLECULAR MEDICINE AND MECHANISMS OF DISEASE FALL 2016 Friday 9:30-12:20 University Hall 444 Instructor: Dr. Julie Jameson Science Hall 1, Room 317 760-750-8274 [email protected] Office Hours: 9:30-10:30AM Wednesday and/or by appointment Final Exam: Combined oral presentation and written exam Dec 9 Course Description This course will provide an in-depth analysis of molecular medicine and advances in the field taught through a combination of didactic methods and the use of case studies. Topics will include basic principles of molecular medicine, discoveries in cellular and molecular biology, disease mechanisms and development, clinical research, biomedical ethics, and personalized medicine. An overview of the process from basic science discovery to therapeutic or vaccine approval is presented using practical aspects of specific historical examples. Lecture instruction may include understanding: how genes are used for personalized medicine, how current devices and therapeutics are used for the detection and treatment of cancer, how animal models of disease are used for pre-clinical studies, how cell-based therapeutics are used to eradicate disease, and how molecular medicine impacts global health. Prerequisites for BIOL 686-4: This class is only open to graduate students. Course Learning Outcomes At the end of the course students will be able to: 1. Understand and explain the organizational requirements for the translation of biomedical therapeutics from bench to bedside. 2. Debate the impact translational research has had on human health and disease. 3. Explain why pharmaceutical companies select particular drug or therapeutic targets for further study. 4. Articulate the significance and potential of molecular medical advances in biomedical research. -
M Sc - Molecular Medicine
Program M Sc - Molecular Medicine 1 Table of Contents Contents Pg. No. 1. PROGRAMME OUTCOMES 3 2. PROGRAMME EDUCATIONAL OBJECTIVES 4 3. CURRICULUM STRUCTURE 5 4. COURSE OBJECTIVES, COURSE OUTCOMES, SYLLABUS 7 2 PROGRAMME OUTCOMES Each graduate will be able to:- ● Develop a sound molecular understanding about the different diseases we encounter and how at molecular level one could tackle the issues to develop diagnostics and therapeutics for the betterment of healthcare. ● Student should be able to design strategies using molecular techniques taught to address issues pertaining to biotechnology development. ● Empower the student with capabilities that help them to take up transnationally oriented projects that help the society. ● Students have a wide option of choosing different medically oriented careers. ● Equip them to approach research confidently due to the hands on training of various techniques and writing manuscripts for publication. ● Student develops the skills to present their work in any forum for better projection of their work and biotechnology skills they acquired. ● As they are introduced to the translational aspects of medicine, they are better geared to innovate start-ups and transform themselves into entrepreneurs. 3 PROGRAMME EDUCATIONAL OBJECTIVES Molecular medicine is the study of molecular and cellular phenomena in biological systems, molecular aspects of human diseases, the human body’s response to diseases, heterogeneity of response and personalized medicine, stem cells, immune response and genetic determinants. The course covers the use of molecular understanding in discovery research in disease prevention, drug development, diagnosis and therapy. One of the unique strengths of this course is its emphasis on an interdisciplinary approach whereby medical sciences, molecular and biochemical aspects of biology is addressed. -
Documentation and Diagnosis of Overweight and Obesity In
Letters intervention, residents were aware that albuterol neb treat- Analysis and interpretation of data: Moriates, Novelero, Khanna, Mourad. ments were more expensive than albuterol MDIs (82%, pre- Drafting of the manuscript: Moriates, Novelero. Critical revision of the manuscript for important intellectual content: Quinn, test; 94%, postintervention [P = .11]). Prior to the interven- Khanna, Mourad. tion 13 of the residents (26%) answered incorrectly that neb Statistical analysis: Khanna. treatments were more efficacious than MDIs, in contrast to only Obtained funding: Novelero. 1 resident (3%) following exposure to our intervention (P < .01). Administrative, technical, and material support: Novelero, Quinn, Mourad. Study supervision: Khanna, Mourad. At baseline, none of the residents agreed that “patients re- Published Online: July 22, 2013. ceive adequate inpatient MDI teaching”; however, this rate im- doi:10.1001/jamainternmed.2013.9002. proved to 16% after the first 2 months of implementation Conflict of Interest Disclosures: None reported. (P < .01). Additional Contributions: Theodore Omachi, MD, MBA (Department of Medicine, University of California, San Francisco), and Sumant Ranji, MD Discussion | Our multifaceted intervention was associated (Department of Medicine, University of California, San Francisco), contributed with a simultaneous decrease in unnecessary neb treat- to the design and implementation of this project. They did not receive compensation. ments, an increase in evidence-based resident physician 1. Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator delivery in knowledge, and potentially an improvement in MDI patient acute airflow obstruction: a meta-analysis. Arch Intern Med. 1997;157(15):1736- education. This concurrent improvement in quality of care 1744. with a decrease in cost maximizes the “value equation” 2. -
2017 Catalog 2017 Catalog
2017CATALOG ABOUT ACS AMERICAN CHEMICAL SOCIETY With more than 157,000 members, the American Chemical Society (ACS) Table of Contents>>> is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. A nonprofit organization chartered by Congress, ACS is at the forefront of the evolving About ACS Publications ................................................................................. 3 worldwide chemical enterprise and the premier professional home for chemists, chemical Editorial Excellence for 138 years ..............................................................................................................4 What Fuels ACS Publications’ Growth ......................................................................................................6 engineers, and related professionals around the globe. ACS Publications’ Unsurpassed Performance .........................................................................................8 ACS Publications’ Impact on Chemistry ................................................................................................ 10 Select Highlights from ACS Journals ...................................................................................................... 12 An Inspiring Online Platform ................................................................................................................... 14 ACS on Campus ..........................................................................................................................................